@newsramp.comCreative Biolabs integrates complement assays, macrophage polarization analysis, and microfluidic solutions into one flexible research platform for biotherapeutics development. A customizable approach to preclinical immune characterization. #Biotherapeutics #Immunology
@newsen.bsky.socialLakewood-Amedex Biotherapeutics Reports Breakthroughs in Antimicrobial Treatments for UTIs and Pulmonary Infections #USA #Sarasota #biotherapeutics #Lakewood-Amedex #Bisphosphocin
@cruk-cityoflondon.bsky.socialAre you interested in doing a #PhD in #cancerresearch?
🧪👩🏿🔬🧫🦠🔬
Do you want to develop new #biotherapeutics?
Are you of black heritage?
Applications for our fully funded 4-year BLiC PhD programme starting in Autumn 2027 are open now!
www.colcc.ac.uk/black-leader...
#BlackLeadersinCancer #CRUK
@cruk-cityoflondon.bsky.socialAre you interested in doing a #PhD in #cancerresearch? 🧪🧑🔬👨🏽🔬👩🏿🔬🧫🦠🔬 Do you want to develop new #biotherapeutics? Applications for our fully funded 4-year PhD programme starting in Autumn 2027 are open now!
www.colcc.ac.uk/phd-recruitm...
#PhD #CancerResearch #UCL #KingsCollege #BartsCancer #TheCrick
@newsen.bsky.socialLakewood-Amedex Biotherapeutics Unveils Promising Results in Diabetic Foot Ulcers Research #United_States #Sarasota #biotherapeutics #Lakewood-Amedex #Nu-3
@newsen.bsky.socialLakewood-Amedex Biotherapeutics Initiates Phase 2a Trial for Diabetic Foot Ulcers Treatment #United_States #Sarasota #biotherapeutics #Lakewood-Amedex #Nu-3
@newsen.bsky.socialLakewood-Amedex Biotherapeutics Announce Participation at H.C. Wainwright Conference #USA #New_York #biotechnology #biotherapeutics #Lakewood-Amedex
@newsen.bsky.socialProtalix BioTherapeutics Set to Engage Investors at October 2026 Conferences #New_York_City #Israel #Investor #biotherapeutics #Protalix